Artichoke

NutraPedia - Evidence-Based Supplement Research

Back to Table of Contents
Health Goals: digestion detox heart

Research Overview

Current research on “artichoke” spans two partially overlapping domains: (1) Jerusalem artichoke (a major industrial source of inulin) and (2) globe artichoke (Cynara scolymus) as a food and botanical supplement. The most-studied areas reflected in these abstracts are inulin’s prebiotic and techno-functional roles (food/pharmaceutical applications such as fat replacement, thickening, and use as an excipient), and the phytochemistry/antioxidant biology of globe artichoke tissues (heads, leaves, bracts) and by-products. For globe artichoke, research frequently characterizes phenolic profiles—especially caffeoylquinic acids and flavonoids such as luteolin and apigenin—and links these constituents to antioxidant potential; there is also interest in valorizing processing wastes as phenolic-rich extracts. A smaller but notable research thread explores agricultural productivity of Jerusalem artichoke via plant growth–promoting rhizobacteria consortia.

The strongest evidence in these abstracts supports inulin’s role as a prebiotic that can measurably modulate the gut microbiome. In particular, a randomized, double-blind, placebo-controlled trial in children with obesity reported increased alpha-diversity and enrichment of taxa commonly interpreted as beneficial (e.g., Bifidobacterium and butyrate-producing bacteria), alongside shifts in inferred microbial functional pathways and correlations with metabolic outcomes. For globe artichoke, the evidence base is strongest for chemical characterization and antioxidant activity across edible parts and processed forms, with consistent identification of phenolic compounds plausibly underlying observed antioxidant capacity. Claims extending to specific clinical benefits (e.g., neuroprotection in Alzheimer’s disease) are currently supported here mainly by mechanistic rationale (antioxidant/anti-inflammatory and anti-acetylcholinesterase activities) and phytochemical profiling rather than definitive clinical efficacy data.

Key gaps include the need for more well-controlled human intervention studies directly testing globe artichoke preparations (leaf extracts, infusions, whole-food forms, and standardized by-product extracts) on clinically meaningful endpoints, with careful attention to dose, formulation, and bioavailability of phenolics. For inulin/Jerusalem artichoke, further research is needed to connect microbiome changes to durable health outcomes across populations, clarify responders vs non-responders, and compare inulin sources and processing methods. Additional priorities include standardized safety/toxicity assessments for concentrated extracts and supplements, improved translation from laboratory findings to real-world applications, and lifecycle/scale-up studies for sustainable use of artichoke agricultural and processing wastes as sources of bioactive compounds.

1. What conditions has Artichoke been studied for?

  • Gut microbiome modulation / dysbiosis (via inulin from Jerusalem artichoke): Studied in childhood obesity with gut dysbiosis outcomes (randomized, double-blind, placebo-controlled trial using inulin extracted from Thai Jerusalem artichoke).

  • Obesity-related metabolic abnormalities: In the same pediatric trial, microbiome changes were linked to clinical and metabolic outcomes (details not fully shown in the abstract excerpt, but the study frames obesity-induced inflammation/metabolic abnormalities as targets).

  • Type 2 diabetes mellitus (T2DM): A randomized trial tested a combined supplement containing prebiotic dietary fiber from rice bran and Jerusalem artichoke plus an antioxidant (anthocyanin) for 60 days, assessing glucose control, lipids, oxidative stress, and inflammation.

  • Liver and biliary/digestive indications (globe artichoke leaf extract; Cynara scolymus): Reviews describe study in contexts aligned with hepatoprotection, choleresis/bile enhancement, and digestive/bowel problems.

  • Hypercholesterolemia / lipid lowering: Artichoke leaf extract is described as having lipid-lowering effects in clinical and experimental work (review). One abstract also discusses nutraceuticals for hypercholesterolemia broadly, but does not provide artichoke-specific results in the excerpt.

  • Postprandial glycemic response: A review notes boiled wild artichoke reduced postprandial glycemic and insulinemic responses in normal subjects, but not in metabolic syndrome patients.

  • Neuroprotection / Alzheimer’s disease (AD) (globe artichoke phenolics): A review proposes artichoke as a multi-target candidate in AD due to antioxidant, anti-inflammatory, and anti-acetylcholinesterase activities; evidence in the excerpt is mechanistic/preclinical-oriented rather than clinical.

  • Antimicrobial and anti-cancer potential: A broad review attributes antimicrobial and anti-cancer biological activities to artichoke parts (heads/leaves), but the excerpt does not describe specific human trials.

2. Does it work in treating those conditions? Summarize the evidence.

  • Childhood obesity (gut microbiome outcomes) — supportive evidence for microbiome modulation

    • In a randomized, double-blind, placebo-controlled study in children with obesity (7–15 years), inulin extracted from Jerusalem artichoke increased alpha-diversity and increased taxa often considered beneficial, including Bifidobacterium and several butyrate-producing bacteria (e.g., Agathobacter, Eubacterium coprostanoligenes, Subdoligranulum), compared with placebo and fiber-advice groups.

    • Functional pathway differences (e.g., proteasome, riboflavin metabolism) were reported and correlated with clinical/metabolic outcomes only in the inulin group (the excerpt does not provide the magnitude of clinical changes).

    • Interpretation: Evidence supports that Jerusalem artichoke–derived inulin can improve dysbiosis markers; whether it meaningfully improves weight or metabolic endpoints cannot be fully judged from the excerpt alone.

  • T2DM (combined supplement including Jerusalem artichoke fiber) — suggestive but not artichoke-isolated

    • A 60-day randomized trial (n=60) tested anthocyanin + prebiotic fiber (rice bran + Jerusalem artichoke) vs maltodextrin and found superior effects on glucose and lipid profiles in the supplement group, including reduced fasting blood glucose (full numeric results not shown in the excerpt).

    • Interpretation: The intervention was multi-ingredient, so the specific contribution of Jerusalem artichoke fiber/inulin cannot be isolated from the abstract excerpt.

  • Liver/biliary and lipid-lowering effects (globe artichoke leaf extract) — evidence described as spanning experimental + clinical, but details limited here

    • A review states artichoke leaf extract is among herbal remedies where clinical and experimental trials have complemented each other, with demonstrated antioxidant, choleretic, hepatoprotective, bile-enhancing, and lipid-lowering effects.

    • It also notes animal studies suggesting liver protection and possible regeneration, but emphasizes research is not yet conclusive.

    • Interpretation: The excerpt supports plausibility and a history of study, but does not provide trial sizes, effect sizes, or specific clinical endpoints, limiting certainty.

  • Postprandial glycemia — mixed evidence

    • A review reports boiled wild artichoke reduced postprandial glycemic and insulinemic responses in normal subjects, but had no effect in metabolic syndrome patients.

    • Interpretation: Effects may depend on baseline metabolic health; evidence in metabolic syndrome appears negative in the cited statement.

  • Alzheimer’s disease — mechanistic/preclinical rationale in excerpt

    • A review argues artichoke could fit a multi-target AD approach due to antioxidant, anti-inflammatory, and anti-acetylcholinesterase activities, and identifies phenolics (e.g., caffeoylquinic acids; flavonoids such as apigenin, luteolin, kaempferol) in artichoke bracts extract.

    • Interpretation: This is hypothesis-generating; the excerpt does not provide human clinical efficacy data for AD.

3. What health benefits does it have?

  • Prebiotic effects (primarily via inulin from Jerusalem artichoke)

    • Reviews describe inulin as a prebiotic with an “outstanding effect” on regulating intestinal microbiota.

    • In children with obesity, inulin increased microbial diversity and increased Bifidobacterium and butyrate-producing bacteria, consistent with improved gut ecosystem function.

  • Potential metabolic benefits (glucose/lipids)

    • Reviews of inulin cite roles in regulating blood sugar and blood lipids (general inulin literature; not artichoke-exclusive).

    • A combined anthocyanin + Jerusalem artichoke fiber supplement improved glucose and lipid profiles in T2DM over 60 days (multi-ingredient intervention).

    • Artichoke leaf extract is described as lipid-lowering in clinical/experimental research (review statement).

  • Antioxidant activity (globe artichoke)

    • A review identifies artichoke’s “primary health-promoting activity” as antioxidant potential, linked to phenolic compounds and dietary fiber; phenolics are quantified in the excerpt as 96 mg gallic acid equivalents per 100 g raw plant material.

    • Key phenolics mentioned include caffeic acid derivatives and flavonoids luteolin and apigenin (as glycosides/rutinosides).

    • Heat-treated artichokes and extracts/by-products are also reported to retain antioxidant activity.

  • Hepatobiliary/digestive support (globe artichoke leaf extract)

    • Review-described effects include choleretic, bile-enhancing, and hepatoprotective actions, aligning with historical digestive use.

  • Neuroprotective mechanistic potential (AD-related targets)

    • Proposed mechanisms include anti-inflammatory, antioxidant, and anti-acetylcholinesterase activities; phenolic-rich extracts from artichoke bracts/wastes are highlighted as sources of relevant compounds.

4. Does it have any downsides or side effects?

  • Evidence limitations in the provided abstracts

    • Although one review mentions “toxicity” as part of its scope, the excerpt provided does not list specific adverse events, contraindications, or incidence rates for artichoke (Cynara scolymus) preparations.

    • The inulin trial excerpt in children with obesity does not describe side effects/tolerability outcomes.

  • Practical caution based on what is studied here

    • Because many benefits discussed are tied to inulin (a fermentable fiber), gastrointestinal effects (e.g., gas/bloating) are common with prebiotic fibers in general, but this is not explicitly reported in the provided excerpts, so frequency/severity cannot be concluded from these abstracts.

    • Different “artichoke” sources are discussed (e.g., Jerusalem artichoke for inulin vs globe artichoke leaf extract for phenolics). Safety profiles may differ by species/part/extract, and the excerpts do not provide comparative safety data.

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

The provided abstracts do not report pharmacogenomic findings for artichoke (globe artichoke extracts) or Jerusalem artichoke–derived inulin. No gene–supplement interactions, genotype-stratified outcomes, or variant-specific safety signals are described, so no evidence-based conclusions can be drawn here about benefits or harms for specific genetic variations.

References

  1. Inulin: properties and health benefits.
    Yu-Qing Qin, Liu-Yan Wang, Xin-Yu Yang, Yi-Jie Xu, Gang Fan, Yan-Ge Fan, Jing-Nan Ren, Qi An, Xiao Li (2023) - Food & function
  2. The Plants of the
    Agata Rolnik, Beata Olas (2021) - International journal of molecular sciences
  3. An Overview of the Versatility of the Parts of the Globe Artichoke (Cynara scolymusL.), Its By-Products and Dietary Supplements
    Beata Olas (2024)
  4. Neuroprotective Effect of Artichoke-Based Nanoformulation in Sporadic Alzheimer's Disease Mouse Model: Focus on Antioxidant, Anti-Inflammatory, and Amyloidogenic Pathways.
    Heba A S El-Nashar, Haidy Abbas, Mariam Zewail, Mohamed H Noureldin, Mai M Ali, Marium M Shamaa, Mohamed A Khattab, Nehal Ibrahim (2022) - Pharmaceuticals (Basel, Switzerland)
  5. The physiological functions and pharmaceutical applications of inulin: A review.
    Xinhuan Wan, Hao Guo, Yiyu Liang, Changzheng Zhou, Zihao Liu, Kunwei Li, Fengju Niu, Xin Zhai, Lizhu Wang (2020) - Carbohydrate polymers
  6. Enhancing gut microbiota and microbial function with inulin supplementation in children with obesity.
    Chonnikant Visuthranukul, Sira Sriswasdi, Surapun Tepaamorndech, Supakarn Chamni, Asada Leelahavanichkul, Yutthana Joyjinda, Vitavat Aksornkitti, Sirinuch Chomtho (2024) - International journal of obesity (2005)
  7. The combination of multiple plant growth promotion and hydrolytic enzyme producing rhizobacteria and their effect on Jerusalem artichoke growth improvement.
    Natthawat Sritongon, Sophon Boonlue, Wiyada Mongkolthanaruk, Sanun Jogloy, Nuntavun Riddech (2023) - Scientific reports
  8. Functional and Therapeutic Potential of
    Chiara Porro, Tarek Benameur, Antonia Cianciulli, Mirco Vacca, Margherita Chiarini, Maria De Angelis, Maria Antonietta Panaro (2024) - Nutrients
  9. Functional and therapeutic potential of inulin: A comprehensive review.
    Waqas Ahmed, Summer Rashid (2019) - Critical reviews in food science and nutrition
  10. Plant-Derived Bioactive Compounds: Exploring Neuroprotective, Metabolic, and Hepatoprotective Effects for Health Promotion and Disease Prevention.
    Rosa Direito, Sandra Maria Barbalho, Bruno Sepodes, Maria Eduardo Figueira (2024) - Pharmaceutics
  11. Plant Prebiotics and Their Role in the Amelioration of Diseases.
    Amrit Pal Kaur, Sonali Bhardwaj, Daljeet Singh Dhanjal, Eugenie Nepovimova, Natália Cruz-Martins, Kamil Kuča, Chirag Chopra, Reena Singh, Harsh Kumar, Fatih Șen, Vinod Kumar, Rachna Verma, Dinesh Kumar (2021) - Biomolecules
  12. Pharmacological Studies of Artichoke Leaf Extract and Their Health Benefits.
    Maryem Ben Salem, Hanen Affes, Kamilia Ksouda, Raouia Dhouibi, Zouheir Sahnoun, Serria Hammami, Khaled Mounir Zeghal (2015) - Plant foods for human nutrition (Dordrecht, Netherlands)
  13. Byproducts of Globe Artichoke and Cauliflower Production as a New Source of Bioactive Compounds in the Green Economy Perspective: An NMR Study.
    Cinzia Ingallina, Giacomo Di Matteo, Mattia Spano, Erica Acciaro, Enio Campiglia, Luisa Mannina, Anatoly Petrovich Sobolev (2023) - Molecules (Basel, Switzerland)
  14. Diabetes Therapeutics of Prebiotic Soluble Dietary Fibre and Antioxidant Anthocyanin Supplement in Patients with Type 2 Diabetes: Randomised Placebo-Controlled Clinical Trial.
    Chompoonut Teparak, Juntanee Uriyapongson, Jatuporn Phoemsapthawee, Orathai Tunkamnerdthai, Ploypailin Aneknan, Terdthai Tong-Un, Charnchai Panthongviriyakul, Naruemon Leelayuwat, Ahmad Alkhatib (2025) - Nutrients
  15. A network meta-analysis on the comparative effect of nutraceuticals on lipid profile in adults.
    Tadeusz Osadnik, Marcin Goławski, Piotr Lewandowski, Jakub Morze, Kamila Osadnik, Natalia Pawlas, Mateusz Lejawa, Grzegorz K Jakubiak, Agnieszka Mazur, Lucas Schwingschackl, Mariusz Gąsior, Maciej Banach (2022) - Pharmacological research
  16. Natural Products as Hepatoprotective Agents-A Comprehensive Review of Clinical Trials.
    Piotr Służały, Paweł Paśko, Agnieszka Galanty (2024) - Plants (Basel, Switzerland)
  17. Lipid-lowering activity of artichoke extracts: A systematic review and meta-analysis.
    Amirhossein Sahebkar, Matteo Pirro, Maciej Banach, Dimitri P Mikhailidis, Stephen L Atkin, Arrigo F G Cicero (2018) - Critical reviews in food science and nutrition
  18. Phenolic Composition of Artichoke Waste and its Antioxidant Capacity on Differentiated Caco-2 Cells.
    Nerea Jiménez-Moreno, María José Cimminelli, Francesca Volpe, Raul Ansó, Irene Esparza, Inés Mármol, María Jesús Rodríguez-Yoldi, Carmen Ancín-Azpilicueta (2019) - Nutrients
  19. Efficacy of artichoke leaf extract in non-alcoholic fatty liver disease: A pilot double-blind randomized controlled trial.
    Yunes Panahi, Parisa Kianpour, Reza Mohtashami, Stephen L Atkin, Alexandra E Butler, Ramezan Jafari, Roghayeh Badeli, Amirhossein Sahebkar (2018) - Phytotherapy research : PTR
  20. The effect of artichoke on lipid profile: A review of possible mechanisms of action.
    Heitor Oliveira Santos, Allain Amador Bueno, João Felipe Mota (2018) - Pharmacological research


Want personalized supplement recommendations based on your genetics?
Upload Whole Genome Sequencing (WGS) raw DNA data today!
Or upload raw DNA data to get started with your free analysis!